↓ Skip to main content

Pharmacology of Immunosuppression

Overview of attention for book
Attention for Chapter 548: Immunosuppression in Lung Transplantation.
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
10 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Immunosuppression in Lung Transplantation.
Chapter number 548
Book title
Pharmacology of Immunosuppression
Published in
Handbook of experimental pharmacology, November 2021
DOI 10.1007/164_2021_548
Pubmed ID
Book ISBNs
978-3-03-105117-3, 978-3-03-105118-0
Authors

Nelson, Joelle, Kincaide, Elisabeth, Schulte, Jamie, Hall, Reed, Levine, Deborah Jo

Abstract

Immunosuppression in lung transplantation is an area devoid of robust clinical data. This chapter will review the history of immunosuppression in lung transplantation. Additionally, it will evaluate the three classes of induction, maintenance, and rescue immunosuppression in detail. Induction immunosuppression in lung transplantation aims to decrease incidence of lung allograft rejection, however infectious risk must be considered when determining if induction is appropriate and which agent is most favorable. Similar to other solid organ transplant patient populations, a multi-drug approach is commonly prescribed for maintenance immunosuppression to minimize single agent drug toxicities. Emphasis of this review is placed on key medication considerations including dosing, adverse effects, and drug interactions. Clinical considerations will be reviewed per drug class given available literature. Finally, acute cellular, antibody mediated, and chronic rejection are reviewed.

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 4%
Unknown 22 96%

Demographic breakdown

Readers by professional status Count As %
Other 3 13%
Student > Master 3 13%
Student > Postgraduate 2 9%
Student > Bachelor 1 4%
Professor 1 4%
Other 4 17%
Unknown 9 39%
Readers by discipline Count As %
Medicine and Dentistry 7 30%
Biochemistry, Genetics and Molecular Biology 2 9%
Psychology 2 9%
Immunology and Microbiology 1 4%
Business, Management and Accounting 1 4%
Other 1 4%
Unknown 9 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 January 2022.
All research outputs
#4,614,654
of 23,314,015 outputs
Outputs from Handbook of experimental pharmacology
#154
of 650 outputs
Outputs of similar age
#111,282
of 509,928 outputs
Outputs of similar age from Handbook of experimental pharmacology
#1
of 7 outputs
Altmetric has tracked 23,314,015 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 650 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 509,928 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them